FN1 and prostate cancer: Furthermore, treatment of prostate cancer cells with ZEB1 siRNA results in a more epithelial morphology, with increased expression of E-cadherin and decreased N-cadherin, fibronectin expression, and suppresses prostate cancer cell migration and invasion.